In this prospective study, Starke et al. investigated the effects of administration of ε aminocaproic acid (EACA) for a maximum of 72 h from the time of diagnosis of subarachnoid hemorrhage.
Aminocaproic acid 250mg/mL; raspberry-flavor. When there is uncertainty as to whether the cause of bleeding is primary fibrinolysis or disseminated intravascular coagulation (DIC), this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback